Assignee
JANSSEN BIOPHARMA INC
US·21 granted patents·15 pending applications·39 citations·filing 2013–2024
Top patents by PatentIndex Score
36 records- 0195US12030907B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2021·Granted Jul 9, 2024·2 cites·18 claims
- 0295US10487104B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Nov 26, 2019·6 cites·20 claims
- 0393US10780105B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·4 cites·37 claims
- 0492US10793591B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Oct 6, 2020·2 cites·6 claims
- 0592US10683320B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Jun 16, 2020·2 cites·5 claims
- 0690US11180524B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2018·Granted Nov 23, 2021·4 cites·24 claims
- 0790US10702523B2AZA-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Jul 7, 2020·3 cites·32 claims
- 0887US12428441B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2024·Granted Sep 30, 2025·0 cites·18 claims
- 0985US10696708B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Jun 30, 2020·2 cites·20 claims
- 1084US11149049B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Oct 19, 2021·2 cites·20 claims
- 1184US11021509B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Jun 1, 2021·1 cites·25 claims
- 1284US10793859B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2017·Granted Oct 6, 2020·2 cites·10 claims
- 1383US12077757B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2020·Granted Sep 3, 2024·1 cites·15 claims
- 1480US11021444B2Antiviral compoundsJANSSEN BIOPHARMA INC·Filed 2018·Granted Jun 1, 2021·1 cites·25 claims
- 1578US10980805B2Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 20, 2021·0 cites·9 claims
- 1677US11014935B2Compounds for the treatment of paramyxovirus viral infectionsJANSSEN BIOPHARMA INC·Filed 2017·Granted May 25, 2021·1 cites·8 claims
- 1777US10745427B2Acyclic antiviralsJANSSEN BIOPHARMA INC·Filed 2017·Granted Aug 18, 2020·3 cites·19 claims
- 1876USRE48171ESubstituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2013·Granted Aug 25, 2020·3 cites·57 claims
- 1973US2021179656A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2073US2021186969A1Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2171US2022363640A1Antiviral compoundsJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2268US2022396581A1Compounds for the treatment of paramyxovirus viral infectionsJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2365US2023002409A1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2464US11312727B1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 26, 2022·0 cites·16 claims
- 2562US10905767B2Oligonucleotide constructs and uses thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Feb 2, 2021·0 cites·2 claims
- 2659US2023203078A1Synthesis of 3'n nucleosides through oxime intermediates and related compoundsJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2755US2021196831A1Oligonucleotide constructs and uses thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2854US2024092821A1Synthesis of oligonucleotides and related compoundsJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2952US2023250125A1Nucleic acid polymersJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3050US2023365608A1Antiviral nucleosides and derivatives thereofJANSSEN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3149US12503698B2GalNAc derivativesJANSSEN BIOPHARMA INC·Filed 2018·Granted Dec 23, 2025·0 cites·10 claims
- 3247US2022048912A1Cyclobutyl nucleoside analogs as anti-viralsJANSSEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3347US2019381081A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3446US2022033406A1Cyclopentyl nucleoside analogs as anti-viralsJANSSEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3540US2019169221A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3638US2021015884A1Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JANSSEN BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →